Global Bioenergies strengthens its cash position thanks to several cash inflows coming from public fundings
15 November 2023 - 5:45PM
PRESS RELEASE
Global Bioenergies strengthens its cash
position thanks to several cash inflows coming from public
fundings
Evry, 15 November 2023 – 05:45
p.m.: Global Bioenergies announces the strengthening of
its gross cash position to 14.4 million euros to date (unaudited
cash position), and the extension of its financial visibility until
early 2025 through the collection of several non-dilutive financing
from renowned partners (Bpifrance, ADEME and the European agency
BBI-JU within the framework of the Horizon 2020 research and
innovation programme).
Global Bioenergies has recently received from
these partners several fundings totalling €7.3M, under:
- Plant
construction project (€4.1m): payment of the first
instalment of the funding granted by the French government for the
construction of the world's first biobased isobutene plant. This
funding, totalling €16.4m, was awarded as part of the “Première
Usine” call for projects launched by Bpifrance within the France
2030 plan.
- Several
French and European R&D consortia (€3.2m):receipt of
the balance of the European grant for the Optisochem project aiming
to convert wheat straw into biobased isobutene derivatives (€1.4m);
receipt of the balance of the funding for the ISOPROD programme,
led by ADEME, validating isobutene derivatives in cosmetics
(€1.1m); payment of the advance for the Prénidem project (€0.7m)
out of a total amount awarded by ADEME of €4.4m.
About GLOBAL BIOENERGIES
Global Bioenergies substitutes products of
fossil origin with products of natural origin. In their quest for
naturalness without compromising on performance, the cosmetics
players are the Company's first customers. By 2027, the Company
will be operating its innovative process in a large-scale plant. By
2030, the Company plans to become a leader in the huge emerging
market for sustainable aviation fuels, in order to fight against
global warming. Global Bioenergies is listed on Euronext Growth in
Paris (FR0011052257 - ALGBE). L'Oréal is its largest shareholder,
with a 13.5% stake.
Contacts
GLOBAL BIOENERGIES+33 (0)1 64 98 20
50invest@global-bioenergies.com Follow our
news Receive information about Global Bioenergies
directly by subscribing to our news feed on
https://www.global-bioenergies.com/inscription-newsletter/ Follow
us on LinkedInGlobal Bioenergies |
|
NewCap – Investor
relationsLouis-Victor DelouvrierQuentin
Masséglobalbioenergies@newcap.eu+33 (0)1 44 71 94
94 NewCap – Media relations Nicolas
Merigeauglobalbioenergies@newcap.eu+33 (0)1 44 71 94 98 |
- Global Bioenergies strengthens its cash position thanks to
several cash inflows coming from public fundings
Global Bioenergies (EU:ALGBE)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Global Bioenergies (EU:ALGBE)
Historical Stock Chart
Von Dez 2023 bis Dez 2024